TLIS
Talis Biomedical Corporation Common Stock
TLIS
TLIS
Delisted
TLIS was delisted on the 30th of August, 2024.
18 hedge funds and large institutions have $5.94M invested in Talis Biomedical Corporation Common Stock in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$318K | |
| 2 | +$74.7K | |
| 3 | +$41K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$25.4K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.19K |
Top Sellers
| 1 | -$27.1K | |
| 2 | -$11.3K | |
| 3 | -$3.46K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$2K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$499 |